ESC Guidelines 2389 disclosure forms are kept on file at the European Heart House,
headquarters of the ESC. Any changes in conflict of interest that arise during the writing …

Chronic heart failure (HF) and diabetes mellitus (DM) commonly coexist. Each condition
increases the likelihood of developing the other, and when they occur together in the same …

Background In patients who have vascular disease or high-risk diabetes without heart
failure, angiotensin-converting–enzyme (ACE) inhibitors reduce mortality and morbidity from …

BACKGROUND: Angiotensin-converting enzyme (ACE) inhibitors reduce major
cardiovascular events, but are not tolerated by about 20% of patients. We therefore …

Background A progressive relationship between hemoglobin A 1c (HbA 1c) levels and
cardiovascular (CV) events has been observed in persons with and without diabetes. To our …

The role of the renin-angiotensin-aldosterone system (RAAS) in many cardiovascular
disorders, including hypertension, cardiac hypertrophy, and atherosclerosis, is well …

Cardiovascular disease represents a continuum that starts with risk factors such as
hypertension and progresses to atherosclerosis, target organ damage, and ultimately to …

HTA: hipertensión arterial; PA: presión arterial; PAD: PA diastólica; PAS: PA sistólica. El
diagnóstico de HTA se establecerá tras la comprobación de los valores de PA en 2 o más …

BACKGROUND: Patients who have angioedema after taking angiotensin-converting
enzyme inhibitors (ACE-Is) have been reported to develop angioedema when taking an …

1. Роль доказательной медицины в изменении взглядов на лечение сердечно-
сосудистой патологии Исторически переход на принципы медицины, основанной на …